Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Nature Communications|December 31, 2024
Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomesMatthew Waas, Christina Karamboulas, Benson Z Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell CarcinomaFederica Ganci, Claudio Pulito, Sara Valsoni, et al.Cell Reports. Medicine|May 16, 2026
Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancerPeter Y F Zeng, Jalna Meens, Amir Hossein Karimi, et al.Oral Oncology|December 23, 2019
Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancerMorgan Black, Farhad Ghasemi, Ren X Sun, et al.JAMA Otolaryngology-- Head & Neck Surgery|March 3, 2022
Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft EngraftmentBadr Id Said, Laurie Ailles, Christina Karamboulas, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 18, 2025
MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinomaClaudio Pulito, Sebastiano Vaccarella, Alina Catalina Palcau, et al.Cell Reports. Medicine|January 24, 2026
Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface targetMeinusha Govindarajan, Salvador Mejia-Guerrero, Shawn C Chafe, et al.Cell Genomics|May 10, 2025
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethalityChelsea E Cunningham, Frederick S Vizeacoumar, Yue Zhang, et al.Pageof 3